Brief: Allarity Therapeutics Says On July 14, Got Letter From Nasdaq That Panel Has Concluded Co Regained Compliance With Bid Price, Equity Concerns
17/07/2023 22:18
July 17 (Reuters) - Allarity Therapeutics Inc ALLR.O :
* ALLARITY THERAPEUTICS - ON JULY 14, GOT LETTER FROM NASDAQ
THAT
PANEL HAS CONCLUDED CO REGAINED COMPLIANCE WITH BID PRICE,
EQUITY CONCERNS
Further company coverage: ALLR.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Allarity Therapeutics
See all newsBrief: Allarity Therapeutics Announces Strategic Capital Allocation For Filing Of Spac Registration Statement
Allarity Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Allarity Therapeutics Q2 loss narrows as expenses fall
Allarity Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Allarity Therapeutics Announces The Grant Of Essential U.S. Patent For Its Stenoparib Drp® Companion Diagnostic